Antiphospholipid antibodies affect human endometrial angiogenesis.
about
Obstetrical antiphospholipid syndrome: from the pathogenesis to the clinical and therapeutic implicationsAntiphospholipid antibodies and the placenta: a systematic review of their in vitro effects and modulation by treatmentEffect of Low Molecular Weight Heparins (LMWHs) on antiphospholipid Antibodies (aPL)-mediated inhibition of endometrial angiogenesisTreatment of refractory obstetric antiphospholipid syndrome: the state of the art and new trends in the therapeutic management.Antiphospholipid antibodies attenuate endothelial repair and promote neointima formation in mice.Pathophysiology of the antiphospholipid antibody syndrome.Pathophysiological mechanisms in antiphospholipid syndromeReduced expressions of connexin 43 and VEGF in the first-trimester tissues from women with recurrent pregnancy loss.Cyclosporin A promotes proliferating cell nuclear antigen expression and migration of human cytotrophoblast cells via the mitgen-activated protein kinase-3/1-mediated nuclear factor-κB signaling pathwaysRecurrent miscarriage and autoimmunity.Management of women with recurrent pregnancy losses and antiphospholipid antibody syndrome.The journey of antiphospholipid antibodies from cellular activation to antiphospholipid syndrome.Does APS Impact Women's Fertility?Low molecular weight heparin and aspirin exacerbate human endometrial endothelial cell responses to antiphospholipid antibodies.Aspirin or heparin or both in the treatment of recurrent spontaneous abortion in women with antiphospholipid antibody syndrome: a meta-analysis of randomized controlled trials.Antiphospholipid antibodies affect human endometrial angiogenesis: protective effect of a synthetic peptide (TIFI) mimicking the phospholipid binding site of β(2) glycoprotein I.Modulation of trophoblast angiogenic factor secretion by antiphospholipid antibodies is not reversed by heparin.Etiology of spontaneous abortion before and after the demonstration of embryonic cardiac activity in women with recurrent spontaneous abortion.
P2860
Q26998188-8B708E8C-6031-4808-A683-99585B7FDE7EQ26999710-94DB285B-BE20-418D-923D-8058F0CE7CC5Q28740531-9EFEF5C0-70C2-4CB7-9EE3-1F257220C012Q34476952-600B5AC7-8C2C-49E3-8BEE-5C9A60655CB8Q35070716-E0B8F39C-06EB-4808-8783-8EAE0598353AQ35309024-7DDCB9F8-2FE0-4F58-A435-E3548C096353Q36671159-A776AA20-EE31-4B7D-87E6-060A85B284BEQ37185222-205215D3-07DD-4B4B-A8F1-16E63552A331Q37228796-E06A4596-EF94-4CD5-BFE0-AE2C62821652Q37821493-874AD5D8-C3A6-48C0-9774-9B933CAE7B18Q38092150-00AF367E-1CF9-4023-8BA8-54E1079C9F37Q38374306-EF388EB4-79B4-424B-8422-55E91D4A2563Q38805695-A2D56141-EAAB-41CE-80DD-E723630556B5Q47176561-46456053-8EDF-476C-BB0D-1394F52ACCCCQ47407572-F0A25F5E-81AB-4FA6-B0DB-B8707D7FD221Q51014103-8F789E15-B222-4FCC-B0C0-002C0F093B10Q53250090-D8429089-BAF3-4C04-8C9C-1F0966983226Q53629364-7E5AE94C-530E-4DC9-8B02-656FA500E1E4
P2860
Antiphospholipid antibodies affect human endometrial angiogenesis.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Antiphospholipid antibodies affect human endometrial angiogenesis.
@en
Antiphospholipid antibodies affect human endometrial angiogenesis.
@nl
type
label
Antiphospholipid antibodies affect human endometrial angiogenesis.
@en
Antiphospholipid antibodies affect human endometrial angiogenesis.
@nl
prefLabel
Antiphospholipid antibodies affect human endometrial angiogenesis.
@en
Antiphospholipid antibodies affect human endometrial angiogenesis.
@nl
P2093
P2860
P50
P1476
Antiphospholipid antibodies affect human endometrial angiogenesis
@en
P2093
Alessandro Caruso
Fiorella Di Nicuolo
Riccardo Marana
Roberta Castellani
P2860
P304
P356
10.1095/BIOLREPROD.110.083410
P407
P577
2010-04-14T00:00:00Z